In solid tumors, T-cell therapy may be limited in part by a hostile tumor microenvironment with constraint of T-cell effector function by immune checkpoint receptors.10 Programmed cell death protein-1 (PD-1) is an immune checkpoint receptor that is expressed by therapeutic T cells, host T cells, and other immune cells. The gene discussed is PDCD1; the disease is neoplasm.